Urinary Nitric Oxide Metabolites and Lipid Peroxidation By-Products in Migraine
- 1 February 2003
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 23 (1) , 39-42
- https://doi.org/10.1046/j.1468-2982.2003.00447.x
Abstract
Enhanced endothelium nitric oxide (NO) and superoxide anion release may cause migraine through related cerebral blood flow changes. Thirty subjects suffering from migraine with and without aura and 20 healthy controls were investigated. Urine samples collected for 24 h during and after the migraine attack, and during the headache-free period, were assayed for urinary NO stable metabolites (NOx) and thiobarbituric acid reactive substances (TBARS). During the headache-free period urinary NOx and TBARS levels were higher in migraine sufferers than in controls (NOx 0.77 ± 0.14 vs. 0.28 ± 0.15 mmol/mmol creatinine, P < 0.05; TBARS 0.40 ± 0.19 vs. 0.26 ± 0.13 μmol/mol creatinine, P < 0.05). Also, NOx excretion was higher during the headache-free period than during or after the migraine attack ( P < 0.05). Urinary TBARS were increased during the attack with respect to the headache-free period ( P < 0.05). No differences were observed in the same parameters between sufferers of migraine with and without aura. Urinary NOx and TBARS might be promising as markers of their systemic levels to evaluate the increased vulnerability to oxidative stress in migraine sufferers.Keywords
This publication has 27 references indexed in Scilit:
- Sumatriptan modifies cortical free radical release during cortical spreading depression: A novel antimigraine action for sumatriptan?Brain Research, 2000
- Endogenous nitric oxide synthesis: Biological functions and pathophysiologyFree Radical Research, 1999
- MigraineThe Lancet, 1998
- Use of the Radionics Image Fusion™ and Stereoplan™ programs for target localization in functional neurosurgeryJournal of Clinical Neuroscience, 1998
- The nitric oxide hypothesis of brain agingExperimental Gerontology, 1997
- Nitric oxide is a key molecule in migraine and other vascular headachesTrends in Pharmacological Sciences, 1994
- Sumatriptan: A Receptor-Targeted Treatment for MigraineAnnual Review of Medicine, 1993
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular systemAnnals of Neurology, 1988
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986